Genetic sequencing has become very affordable, with a very fast turnaround time. Researchers are using sequencing technologies to study almost every disease state and form of infection. In terms of diabetes, scientists are studying the genomes of type-2 diabetics to determine if genetic factors affect responses to medication and diet changes, as well as if type-2 diabetes needs a reorganization into different therapeutic categories.
Marylyn Ritchie, PhD
Senior Investigator & Founding Director: Biomedical & Translational Informatics Program
Geisinger Health System